These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 19995397)

  • 1. Activated protein C action in inflammation.
    Sarangi PP; Lee HW; Kim M
    Br J Haematol; 2010 Mar; 148(6):817-33. PubMed ID: 19995397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective mechanisms of activated protein C in severe inflammatory disorders.
    Neyrinck AP; Liu KD; Howard JP; Matthay MA
    Br J Pharmacol; 2009 Oct; 158(4):1034-47. PubMed ID: 19466992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent cytoprotective functions.
    Mosnier LO; Yang XV; Griffin JH
    J Biol Chem; 2007 Nov; 282(45):33022-33. PubMed ID: 17872949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C and sepsis.
    O'Brien LA; Gupta A; Grinnell BW
    Front Biosci; 2006 Jan; 11():676-98. PubMed ID: 16146761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a specific exosite on activated protein C for interaction with protease-activated receptor 1.
    Yang L; Bae JS; Manithody C; Rezaie AR
    J Biol Chem; 2007 Aug; 282(35):25493-500. PubMed ID: 17580306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein C in critical illness.
    Mann HJ; Short MA; Schlichting DE
    Am J Health Syst Pharm; 2009 Jun; 66(12):1089-96. PubMed ID: 19498123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytoprotective protein C pathway.
    Mosnier LO; Zlokovic BV; Griffin JH
    Blood; 2007 Apr; 109(8):3161-72. PubMed ID: 17110453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The numerous properties of the anticoagulant protein C].
    Cerchiara E; Tirindelli MC; Giannetti B; Dicuonzo G; Avvisati G
    Clin Ter; 2007; 158(2):181-7. PubMed ID: 17566522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C variants with normal cytoprotective but reduced anticoagulant activity.
    Mosnier LO; Gale AJ; Yegneswaran S; Griffin JH
    Blood; 2004 Sep; 104(6):1740-4. PubMed ID: 15178575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanisms of action of recombinant human activated Protein C].
    Brueckmann M; Huhle G; Max M
    Anaesthesist; 2006 Jun; 55 Suppl 1():5-15. PubMed ID: 16520928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis.
    Dhainaut JF; Yan SB; Margolis BD; Lorente JA; Russell JA; Freebairn RC; Spapen HD; Riess H; Basson B; Johnson G; Kinasewitz GT;
    Thromb Haemost; 2003 Oct; 90(4):642-53. PubMed ID: 14515185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drotrecogin alfa (activated): a novel therapeutic strategy for severe sepsis.
    Pastores SM
    Postgrad Med J; 2003 Jan; 79(927):5-10. PubMed ID: 12566544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C.
    Kerschen EJ; Fernandez JA; Cooley BC; Yang XV; Sood R; Mosnier LO; Castellino FJ; Mackman N; Griffin JH; Weiler H
    J Exp Med; 2007 Oct; 204(10):2439-48. PubMed ID: 17893198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction induced by activated protein C: no role in protection against sepsis?
    Slofstra SH; ten Cate H; Spek CA
    Trends Mol Med; 2006 Aug; 12(8):374-81. PubMed ID: 16820322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated).
    Macias WL; Yan SB; Williams MD; Um SL; Sandusky GE; Ballard DW; Planquois JM
    Crit Care; 2005; 9 Suppl 4(Suppl 4):S38-45. PubMed ID: 16168074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice.
    Liang HP; Kerschen EJ; Basu S; Hernandez I; Zogg M; Jia S; Hessner MJ; Toso R; Rezaie AR; Fernández JA; Camire RM; Ruf W; Griffin JH; Weiler H
    Blood; 2015 Nov; 126(21):2415-23. PubMed ID: 26341257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia.
    Derhaschnig U; Reiter R; Knöbl P; Baumgartner M; Keen P; Jilma B
    Blood; 2003 Sep; 102(6):2093-8. PubMed ID: 12750166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous protein C has a protective role during Gram-negative pneumosepsis (melioidosis).
    Kager LM; Wiersinga WJ; Roelofs JJ; Meijers JC; Zeerleder SS; Esmon CT; van't Veer C; van der Poll T
    J Thromb Haemost; 2013 Feb; 11(2):282-92. PubMed ID: 23216621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant.
    Mosnier LO; Zampolli A; Kerschen EJ; Schuepbach RA; Banerjee Y; Fernández JA; Yang XV; Riewald M; Weiler H; Ruggeri ZM; Griffin JH
    Blood; 2009 Jun; 113(23):5970-8. PubMed ID: 19244160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protein C pathway and sepsis.
    Della Valle P; Pavani G; D'Angelo A
    Thromb Res; 2012 Mar; 129(3):296-300. PubMed ID: 22154246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.